Mathew Aby J.
SEC CIK 1556355 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | EVP, Chief Scientific Off | 387.3K | — | $13.33M | 130 | 2021-06-29 | 2026-09-18 |
Most active insiders at BLFS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners Master Fund, L.P. | 10% | — | $28.12M |
| 2 | Casdin Partners GP, LLC | 10% | — | $21.41M |
| 3 | DE GREEF RODERICK | Pres, CEO, Dir | — | $3.61M |
| 4 | Foster Karen A. | Chief Quality, Ops | — | $2.07M |
| 5 | Wichterman Troy | CFO | — | $873.5K |
| 6 | DuRoss Amy | Dir | — | $305.7K |
| 7 | Mathew Aby J. | EVP, CSO | — | $65.2K |
| 8 | GOSWAMI JOYDEEP | Dir | — | $48.3K |
| 9 | Aebersold Sarah | CHRO | — | $45.0K |
| 10 | Berard Todd | CMO | — | $42.4K |
Transactions 130
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-24 | 2022-05-22 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | A - Grant | — | +786 | 252.6K | +0.3% | — | |
| 2022-05-17 | 2022-05-13 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $12.32 | -108 | 251.8K | -0.0% | -$1,331 | |
| 2022-04-19 | 2022-04-18 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $17.59 | -19.3K | 251.9K | -7% | -$339.9K | |
| D | 2022-04-13 | 2022-04-12 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | — | +45.7K | 271.2K | +20% | — |
| 2022-03-31 | 2022-03-29 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $22.24 | -658 | 225.5K | -0.3% | -$14.6K | |
| D | 2022-03-09 | 2022-02-24 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | A - Grant | — | +21.0K | 226.6K | +10% | — |
| 2022-03-03 | 2022-03-01 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $23.78 | -412 | 205.2K | -0.2% | -$9,797 | |
| 2022-02-14 | 2022-02-10 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $29.38 | -450 | 205.6K | -0.2% | -$13.2K | |
| DM | 2022-02-04 | 2022-02-02+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | $2.89 | +19.8K | 215.9K | +10% | +$57.3K |
| DM | 2022-02-04 | 2022-02-02+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale+OE | $28.83 | -19.8K | 206.0K | -9% | -$571.9K |
| DM | 2022-01-06 | 2022-01-04+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale+OE | $34.73 | -17.9K | 206.0K | -8% | -$620.1K |
| DM | 2022-01-06 | 2022-01-04+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | $1.40 | +17.9K | 213.9K | +9% | +$25.0K |
| 2021-12-30 | 2021-12-29 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $39.37 | -736 | 206.0K | -0.4% | -$29.0K | |
| DM | 2021-12-08 | 2021-12-06+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | $1.64 | +18.9K | 216.8K | +10% | +$30.9K |
| DM | 2021-12-08 | 2021-12-06+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale+OE | $35.38 | -18.9K | 206.8K | -8% | -$666.9K |
| 2021-12-02 | 2021-11-30 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $37.59 | +448 | 206.8K | +0.2% | +$16.8K | |
| DM | 2021-11-17 | 2021-11-15+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | $1.64 | +20.0K | 217.2K | +10% | +$32.8K |
| DM | 2021-11-17 | 2021-11-15+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale+OE | $49.59 | -20.0K | 207.2K | -9% | -$991.8K |
| DM | 2021-10-20 | 2021-10-18+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | M - OptEx | $1.64 | +20.0K | 217.2K | +10% | +$32.8K |
| DM | 2021-10-20 | 2021-10-18+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale+OE | $41.66 | -20.0K | 207.2K | -9% | -$833.1K |
| 2021-10-18 | 2021-10-14 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, CSO | S - Sale | $39.97 | -1,273 | 207.2K | -0.6% | -$50.9K | |
| 2021-09-30 | 2021-09-28 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale | $43.12 | -719 | 208.5K | -0.3% | -$31.0K | |
| DM | 2021-09-22 | 2021-09-20+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale+OE | $46.94 | -20.0K | 209.2K | -9% | -$938.8K |
| DM | 2021-09-22 | 2021-09-20+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | M - OptEx | $1.64 | +20.0K | 219.2K | +10% | +$32.8K |
| 2021-08-30 | 2021-08-27 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale | $57.26 | -399 | 209.2K | -0.2% | -$22.8K | |
| DM | 2021-08-25 | 2021-08-23+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale+OE | $49.83 | -20.0K | 209.6K | -9% | -$996.6K |
| DM | 2021-08-25 | 2021-08-23+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | M - OptEx | $1.64 | +20.0K | 219.6K | +10% | +$32.8K |
| DM | 2021-07-21 | 2021-07-19+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | M - OptEx | $1.64 | +18.9K | 219.6K | +9% | +$30.9K |
| DM | 2021-07-21 | 2021-07-19+ | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale+OE | $44.68 | -18.9K | 209.6K | -8% | -$842.3K |
| 2021-07-01 | 2021-06-29 | BLFS | BIOLIFE SOLUTIONS INC | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale | $43.75 | -715 | 209.6K | -0.3% | -$31.3K |
Purchase Sale Sale after option exercise All abbreviations